3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Tumor-Agnostic
1
Classical hematology
1
Conditions
Sepsis
1
Neoplasms
1
Febrile Neutropenia
1
Emergencies
1
Interventions
avatrombopag
5
iron isomaltoside 1000
4
hetrombopag
3
ferric carboxymaltose
3
Cytarabine
3
eltrombopag
2
Rivaroxaban
2
Radiotherapy
2
Meropenem
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Erythropoietin
2
Cyclophosphamide
2
Azacitidine
2
thymoglobulin
1
stinging nettle lectin
1
romiplostim
1
raltitrexed
1
peppermint oil
1
pegfilgrastim
1
oprelvekin
1
fludarabine phosphate
1
fludarabine
1
ferrous succinate
1
ferrous fumarate
1
ferric derisomaltose
1
epoetin beta
1
cc-486
1
Vitamin B 12
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Anti-Bacterial Agents
×
Classical hematology
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled